Domperidone for severe stomach movement problems
Treatments studied
Part of Digestive system clinical trials.
This trial looks at whether domperidone can help people ages 12–21 with symptoms from stomach not moving well when usual treatments haven’t worked. It’s designed for cases where other causes have been ruled out and patients are monitored for possible heart and hormone side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 12 to 21
- You have ongoing stomach or throat/respiratory symptoms related to reflux or poor gut movement that did not improve with standard treatments
- Doctors have checked to rule out other possible causes of your symptoms
- You (and your parent/guardian, if needed) can sign consent to take domperidone and understand its risks
- You must not have known allergy to domperidone
- You must not be pregnant or breastfeeding (if you are female)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether domperidone can help people whose stomach or reflux symptoms did not improve with usual treatments. It focuses on symptoms like slow stomach emptying, hard-to-control acid reflux, or severe indigestion.
This study studies how a standardized meal affects digestion using special monitoring in children and young adults with stomach or gut symptom problems (and compares them to healthy controls). It may help doctors understand what causes gut symptoms and guide better treatments.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
This study looks at whether abnormal function of the pyloric “stomach outlet” muscle is linked to gastroparesis symptoms (slow stomach emptying). It may help researchers better understand what causes symptoms and guide future treatments.
This trial tests a device that sends mild electrical pulses to the stomach to help control severe nausea and vomiting caused by gastroparesis (stomach that empties slowly). It is for people aged 18–70 whose symptoms have not improved with medication.
This trial tests if domperidone, a medicine that helps the stomach empty faster, can improve blood sugar levels in people with type 1 diabetes who have slow stomach emptying but few symptoms. If you have type 1 diabetes, use an insulin pump or multiple daily injections, and have a continuous glucose monitor (CGM), this study might be for you.
Hear when a new Gastroesophageal Reflux trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.